Acurx Pharmaceuticals Inc banner

Acurx Pharmaceuticals Inc
NASDAQ:ACXP

Watchlist Manager
Acurx Pharmaceuticals Inc Logo
Acurx Pharmaceuticals Inc
NASDAQ:ACXP
Watchlist
Price: 1.42 USD 1.43% Market Closed
Market Cap: $6.1m

Wall St Price Targets

ACXP Price Targets Summary
Acurx Pharmaceuticals Inc

There are no price targets for ACXP.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Acurx Pharmaceuticals Inc Competitors:
Price Targets
FAST
Fastenal Co
0% Downside
FANG
Diamondback Energy Inc
16% Upside
ANY
ANY Biztonsagi Nyomda Nyrt
19% Upside
INBK
First Internet Bancorp
5% Upside
MEDP
Medpace Holdings Inc
-2% Downside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ACXP's stock price target?
Not Available

ACXP does not have any price targets made by Wall Street professionals.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett